Skip to main content

clinical trial Archives

Glucose control study gives patients new path to health

Oct. 24, 2013—The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating.

Read more


VU tracking drug’s ability to prevent type 1 diabetes

Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

Read more


Defining patient retention

Jul. 15, 2013—Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.

Read more


Continuity of care initiative focuses on patients exiting clinical trials

May. 30, 2013—The Vanderbilt Breast Center is piloting new measures to ensure continuity of care and timely insurance preauthorization as patients come off grant-sponsored clinical trial protocols and begin or resume standard care.

Read more


ResearchMatch adds registry for autism disorders

Jan. 31, 2013—ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.

Read more


Better blood pressure-reducing drugs?

Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

Read more


Matchmaker for clinical studies

Feb. 8, 2012—ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.

Read more


Vanderbilt Heart to participate in CoreValve clinical trial

Apr. 18, 2011—Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more